Missense variants in DPYSL5 cause a neurodevelopmental disorder with corpus callosum agenesis and cerebellar abnormalities.


Journal

American journal of human genetics
ISSN: 1537-6605
Titre abrégé: Am J Hum Genet
Pays: United States
ID NLM: 0370475

Informations de publication

Date de publication:
06 05 2021
Historique:
received: 23 12 2020
accepted: 01 04 2021
pubmed: 25 4 2021
medline: 1 7 2021
entrez: 24 4 2021
Statut: ppublish

Résumé

The collapsin response mediator protein (CRMP) family proteins are intracellular mediators of neurotrophic factors regulating neurite structure/spine formation and are essential for dendrite patterning and directional axonal pathfinding during brain developmental processes. Among this family, CRMP5/DPYSL5 plays a significant role in neuronal migration, axonal guidance, dendrite outgrowth, and synapse formation by interacting with microtubules. Here, we report the identification of missense mutations in DPYSL5 in nine individuals with brain malformations, including corpus callosum agenesis and/or posterior fossa abnormalities, associated with variable degrees of intellectual disability. A recurrent de novo p.Glu41Lys variant was found in eight unrelated patients, and a p.Gly47Arg variant was identified in one individual from the first family reported with Ritscher-Schinzel syndrome. Functional analyses of the two missense mutations revealed impaired dendritic outgrowth processes in young developing hippocampal primary neuronal cultures. We further demonstrated that these mutations, both located in the same loop on the surface of DPYSL5 monomers and oligomers, reduced the interaction of DPYSL5 with neuronal cytoskeleton-associated proteins MAP2 and βIII-tubulin. Our findings collectively indicate that the p.Glu41Lys and p.Gly47Arg variants impair DPYSL5 function on dendritic outgrowth regulation by preventing the formation of the ternary complex with MAP2 and βIII-tubulin, ultimately leading to abnormal brain development. This study adds DPYSL5 to the list of genes implicated in brain malformation and in neurodevelopmental disorders.

Identifiants

pubmed: 33894126
pii: S0002-9297(21)00135-X
doi: 10.1016/j.ajhg.2021.04.004
pmc: PMC8206156
pii:
doi:

Substances chimiques

MAP2 protein, human 0
Microtubule-Associated Proteins 0
TUBB3 protein, human 0
Tubulin 0
DPYSL5 protein, human EC 3.-
Hydrolases EC 3.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

951-961

Subventions

Organisme : NHGRI NIH HHS
ID : UM1 HG008900
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS119263
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NINDS NIH HHS
ID : R01 NS058721
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS050375
Pays : United States
Organisme : NHGRI NIH HHS
ID : R01 HG009141
Pays : United States

Informations de copyright

Copyright © 2021 American Society of Human Genetics. All rights reserved.

Références

Sci Rep. 2017 Sep 6;7(1):10681
pubmed: 28878401
Cell Mol Life Sci. 2018 Jan;75(1):67-79
pubmed: 28864883
Neurochem Int. 2020 Oct;139:104795
pubmed: 32652266
J Med Genet. 2013 Dec;50(12):819-22
pubmed: 24065355
Nature. 2017 Feb 23;542(7642):433-438
pubmed: 28135719
Acta Neuropathol. 2021 Feb;141(2):139-158
pubmed: 33226471
J Neurosci. 2001 Sep 15;21(18):7203-14
pubmed: 11549731
Am J Med Genet A. 2005 Apr 1;134A(1):3-11
pubmed: 15704124
Nature. 2014 Nov 13;515(7526):209-15
pubmed: 25363760
J Biol Chem. 2000 Dec 1;275(48):37957-65
pubmed: 10956643
Curr Opin Genet Dev. 2020 Dec;65:195-206
pubmed: 32846283
Cell Mol Life Sci. 2021 Mar;78(6):2517-2563
pubmed: 33263776
J Comp Neurol. 2005 May 23;486(1):1-17
pubmed: 15834957
Commun Integr Biol. 2010 Mar;3(2):172-5
pubmed: 20585514
Brain. 2014 Jun;137(Pt 6):1579-613
pubmed: 24477430
Front Cell Neurosci. 2020 Jun 23;14:188
pubmed: 32655376
Am J Hum Genet. 2019 Sep 5;105(3):606-615
pubmed: 31474318
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
J Neurochem. 2013 Jun;125(6):855-68
pubmed: 23373749
Neuropharmacology. 2019 Oct;157:107673
pubmed: 31233825
Eur J Hum Genet. 2015 May;23(5):633-8
pubmed: 24916641
J Med Genet. 2020 Apr;57(4):245-253
pubmed: 31712251
Mol Psychiatry. 2015 Sep;20(9):1037-45
pubmed: 26077693
Mol Neurobiol. 2003 Aug;28(1):51-64
pubmed: 14514985
J Neurosci. 2011 Feb 2;31(5):1773-9
pubmed: 21289187
Nature. 2014 Nov 13;515(7526):216-21
pubmed: 25363768
J Neurosci. 2010 Aug 11;30(32):10639-54
pubmed: 20702696
Brain Sci. 2020 Sep 09;10(9):
pubmed: 32916978
J Neurochem. 2006 Apr;97 Suppl 1:16-23
pubmed: 16635246
Science. 2020 Nov 13;370(6518):
pubmed: 33184181
Pediatrics. 2019 Oct;144(4):
pubmed: 31558576
Am J Med Genet. 1987 Feb;26(2):481-91
pubmed: 3812597
Acta Biomed. 2020 Nov 09;91(13-S):e2020003
pubmed: 33170170
Neurobiol Dis. 2020 Mar;136:104709
pubmed: 31843706
Sci Rep. 2017 Dec 1;7(1):16812
pubmed: 29196732

Auteurs

Médéric Jeanne (M)

UMR 1253, iBrain, Université de Tours, Inserm, 37032 Tours, France; Service de Génétique, Centre Hospitalier Universitaire, 37044 Tours, France.

Hélène Demory (H)

UMR 1253, iBrain, Université de Tours, Inserm, 37032 Tours, France.

Aubin Moutal (A)

Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724, USA.

Marie-Laure Vuillaume (ML)

UMR 1253, iBrain, Université de Tours, Inserm, 37032 Tours, France; Service de Génétique, Centre Hospitalier Universitaire, 37044 Tours, France.

Sophie Blesson (S)

Service de Génétique, Centre Hospitalier Universitaire, 37044 Tours, France.

Rose-Anne Thépault (RA)

UMR 1253, iBrain, Université de Tours, Inserm, 37032 Tours, France.

Sylviane Marouillat (S)

UMR 1253, iBrain, Université de Tours, Inserm, 37032 Tours, France.

Judith Halewa (J)

UMR 1253, iBrain, Université de Tours, Inserm, 37032 Tours, France.

Saskia M Maas (SM)

Department of Clinical Genetics, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands.

M Mahdi Motazacker (MM)

Department of Clinical Genetics, Laboratory of Genome Diagnostics, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands.

Grazia M S Mancini (GMS)

Department of Clinical Genetics, Erasmus MC University Medical Center, 30125 CN Rotterdam, the Netherlands.

Marjon A van Slegtenhorst (MA)

Department of Clinical Genetics, Erasmus MC University Medical Center, 30125 CN Rotterdam, the Netherlands.

Avgi Andreou (A)

West Midlands Regional Clinical Genetics Service, Birmingham Women's and Children's Hospital, National Health Service Foundation Trust, Birmingham BT15 2TG, UK; Birmingham Health Partners, Birmingham Women's and Children's Hospital, National Health Service Foundation Trust, Birmingham BT15 2TG, UK.

Helene Cox (H)

West Midlands Regional Clinical Genetics Service, Birmingham Women's and Children's Hospital, National Health Service Foundation Trust, Birmingham BT15 2TG, UK; Birmingham Health Partners, Birmingham Women's and Children's Hospital, National Health Service Foundation Trust, Birmingham BT15 2TG, UK.

Julie Vogt (J)

West Midlands Regional Clinical Genetics Service, Birmingham Women's and Children's Hospital, National Health Service Foundation Trust, Birmingham BT15 2TG, UK; Birmingham Health Partners, Birmingham Women's and Children's Hospital, National Health Service Foundation Trust, Birmingham BT15 2TG, UK.

Jason Laufman (J)

Department of Clinical Genetics, Akron Children's Hospital, Akron, OH 44308-1062, USA.

Natella Kostandyan (N)

Department of Medical Genetics, Yerevan State Medical University after Mkhitar Heratsi, and Center of Medical Genetics and Primary Health Care, Yerevan 0001, Armenia.

Davit Babikyan (D)

Department of Medical Genetics, Yerevan State Medical University after Mkhitar Heratsi, and Center of Medical Genetics and Primary Health Care, Yerevan 0001, Armenia.

Miroslava Hancarova (M)

Department of Biology and Medical Genetics, Charles University 2(nd) Faculty of Medicine and University Hospital Motol, Charles University, Prague 15006, Czech Republic.

Sarka Bendova (S)

Department of Biology and Medical Genetics, Charles University 2(nd) Faculty of Medicine and University Hospital Motol, Charles University, Prague 15006, Czech Republic.

Zdenek Sedlacek (Z)

Department of Biology and Medical Genetics, Charles University 2(nd) Faculty of Medicine and University Hospital Motol, Charles University, Prague 15006, Czech Republic.

Kimberly A Aldinger (KA)

Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA 98101, USA.

Elliott H Sherr (EH)

Departments of Neurology and Pediatrics, Weill Institute of Neuroscience and Institute of Human Genetics, University of California, San Francisco, San Francisco, CA 94158, USA.

Emanuela Argilli (E)

Departments of Neurology and Pediatrics, Weill Institute of Neuroscience and Institute of Human Genetics, University of California, San Francisco, San Francisco, CA 94158, USA.

Eleina M England (EM)

Center for Mendelian Genomics, Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.

Séverine Audebert-Bellanger (S)

Service de Génétique Médicale et de Biologie de la Reproduction, Centre Hospitalier Régional Universitaire, 29200 Brest, France.

Dominique Bonneau (D)

Department of Biochemistry and Genetics, Angers University Hospital and UMR CNRS 6015-INSERM 1083, University of Angers, 49933 Angers, France.

Estelle Colin (E)

Department of Biochemistry and Genetics, Angers University Hospital and UMR CNRS 6015-INSERM 1083, University of Angers, 49933 Angers, France.

Anne-Sophie Denommé-Pichon (AS)

Centre Hospitalier Universitaire de Dijon, UMR Inserm 1231, Team Génétique des Anomalies du Développement, Université de Bourgogne Franche-Comté, 21070 Dijon, France.

Brigitte Gilbert-Dussardier (B)

Service de Génétique, Centre Hospitalier Universitaire, 86021 Poitiers, France; Equipe d'Accueil 3808, Université de Poitiers, 86034 Poitiers, France.

Bertrand Isidor (B)

Service de Génétique Médicale, Centre Hospitalier Universitaire, 44093 Nantes, France; Université de Nantes, CHU Nantes, CNRS, INSERM, l'Institut du Thorax, 44007 Nantes, France.

Sébastien Küry (S)

Service de Génétique Médicale, Centre Hospitalier Universitaire, 44093 Nantes, France; Université de Nantes, CHU Nantes, CNRS, INSERM, l'Institut du Thorax, 44007 Nantes, France.

Sylvie Odent (S)

Service de Génétique Clinique, Centre Référence Déficiences Intellectuelles de Causes Rares, Centre de Référence Anomalies du Développement, Centre Labellisé pour les Anomalies du Développement Ouest, Centre Hospitalier Universitaire de Rennes, 35203 Rennes, France; Institut de Génétique et Développement de Rennes, CNRS, UMR 6290, Université de Rennes, 35043 Rennes, France.

Richard Redon (R)

Université de Nantes, CHU Nantes, CNRS, INSERM, l'Institut du Thorax, 44007 Nantes, France.

Rajesh Khanna (R)

Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724, USA.

William B Dobyns (WB)

Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA 98101, USA; Department of Pediatrics, University of Washington, Seattle, WA 98015, USA.

Stéphane Bézieau (S)

Service de Génétique Médicale, Centre Hospitalier Universitaire, 44093 Nantes, France; Université de Nantes, CHU Nantes, CNRS, INSERM, l'Institut du Thorax, 44007 Nantes, France.

Jérôme Honnorat (J)

French Reference Center on Autoimmune Encephalitis, Hospices Civils de Lyon, Institut NeuroMyoGene, Inserm U1217/CNRS UMR 5310, Université de Lyon, Université Claude Bernard Lyon 1, 69008 Lyon, France.

Bernhard Lohkamp (B)

Division of Molecular Structural Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 17177 Stockholm, Sweden.

Annick Toutain (A)

UMR 1253, iBrain, Université de Tours, Inserm, 37032 Tours, France; Service de Génétique, Centre Hospitalier Universitaire, 37044 Tours, France.

Frédéric Laumonnier (F)

UMR 1253, iBrain, Université de Tours, Inserm, 37032 Tours, France; Service de Génétique, Centre Hospitalier Universitaire, 37044 Tours, France. Electronic address: frederic.laumonnier@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH